Welcome to our dedicated page for Sunopta SEC filings (Ticker: STKL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SunOpta Inc. (STKL, SOY) is a Canada-incorporated manufacturer of plant-based beverages, broths and better-for-you snacks that files reports with the U.S. Securities and Exchange Commission. As a cross-listed issuer on Nasdaq and the Toronto Stock Exchange, SunOpta uses SEC filings to provide detailed information on its financial condition, results of operations and material events.
Among the key documents available for SunOpta are annual reports on Form 10‑K and quarterly reports on Form 10‑Q, which present revenue from continuing operations, earnings from continuing operations, adjusted earnings, adjusted EBITDA and discussions of volume growth across beverages, broths and fruit snacks. These filings also describe factors affecting gross margins, capital allocation priorities, leverage targets, tariff impacts and the company’s approach to pass-through pricing with customers.
Current reports on Form 8‑K are particularly relevant for tracking SunOpta’s material announcements. For example, the company has filed 8‑Ks to furnish press releases reporting financial results for specific quarters, under Item 2.02 Results of Operations and Financial Condition. These filings link directly to earnings releases that discuss recent performance, updates to revenue and adjusted EBITDA outlooks, and commentary on operational initiatives.
On this page, investors can access SunOpta’s SEC filings as they are made available through EDGAR, along with AI-powered summaries designed to highlight the most important points in lengthy documents. The filings list also provides a path to insider transaction reports on Form 4, as well as proxy and other governance-related filings, helping users analyze SunOpta’s regulatory disclosures, compensation decisions and ownership changes alongside its reported financial results.
SunOpta Inc. files Post-Effective Amendment No. 1 to terminate and deregister all unsold securities under six prior Form S-3 registration statements. The amendments follow a court-approved plan of arrangement in which Purchaser Pegasus BidCo B.V. acquired all issued and outstanding SunOpta common shares on May 1, 2026.
The filings remove from registration up to 850,000, 196,809, 1,863,744, 4,250,000, 5,358,794, and 112,500 common shares that had been registered for resale under the listed Registration Statements.
SunOpta Inc. files post-effective amendments to withdraw and terminate six Form S-3 registration statements, removing from registration the unsold securities previously covered by those statements.
The amendments specifically identify Registration Nos. 333-180647 (up to 850,000 common shares), 333-109016 (up to 196,809 common shares), 333-104423 (up to 1,863,744 common shares), 333-83096 (up to 4,250,000 common shares), 333-65656 (up to 5,358,794 common shares), and 333-62388 (up to 112,500 common shares). The deregistration follows a court-approved plan of arrangement under which all issued common shares were acquired on May 1, 2026.
SunOpta Inc. has filed post-effective amendments to terminate and withdraw six Form S-3 registration statements and to remove from registration any unsold securities covered by those statements. The actions follow an acquisition in which 2786694 Alberta Ltd., a wholly‑owned subsidiary of Pegasus BidCo B.V., acquired all issued and outstanding common shares of the company May 1, 2026 by way of a court‑approved statutory plan of arrangement under the Canada Business Corporations Act. As a result, the Registrant states it has terminated offerings and removed from registration all securities that remained unsold under the listed Registration Statements.
SunOpta Inc. filed Post-Effective Amendment No. 1 to multiple Form S-3 registration statements on May 1, 2026 to terminate and withdraw the unsold securities registered for resale under those registrations. The registrant states the deregistration follows a court-approved plan of arrangement under the Canada Business Corporations Act through which Pegasus BidCo B.V.'s wholly owned purchaser acquired all issued and outstanding common shares.
The amendment lists six prior S-3 filings and the specific registered resale amounts for each registration and states that, after the amendment, no securities remain registered under those registration statements.
SunOpta Inc. has filed an amended annual report to add previously omitted Part III information on directors, executive compensation, governance, and ownership, without changing any financial statements from the original filing. The amendment also notes an Arrangement Agreement under which Refresco will acquire all outstanding SunOpta common shares for $6.50 per share in cash via a court-approved plan of arrangement under the Canada Business Corporations Act.
The transaction is expected to close in the second quarter of 2026, after closing conditions are met, after which SunOpta will become a wholly owned subsidiary of Refresco and its shares will be delisted from the Nasdaq Stock Market and the Toronto Stock Exchange. The filing also details SunOpta’s pay-for-performance executive compensation program, including EBITDA-based annual incentives, multi‑year performance stock units, and stock ownership and clawback policies.
Wickramasinghe Mahes reported acquisition or exercise transactions in this Form 4 filing.
SunOpta Inc. director Mahes Wickramasinghe received an award of 1,440 Common Shares on April 17, 2026. The shares were issued in lieu of cash for service on the board of directors, reflecting stock-based compensation rather than an open-market purchase. Following this grant, the director directly holds 51,218 Common Shares.
KEATING LESLIE STARR reported acquisition or exercise transactions in this Form 4 filing.
SunOpta Inc. director Leslie Starr Keating received a grant of 3,332 Common Shares on April 17, 2026 at an indicated value of $6.47 per share. The shares were issued in lieu of cash for service on the board of directors, reflecting stock-based compensation rather than an open-market purchase. Following this award, Keating directly holds 148,311 Common Shares of SunOpta, indicating the transaction is a modest, routine adjustment to an existing equity position.
Reynoso Diego reported acquisition or exercise transactions in this Form 4 filing.
SunOpta Inc. director Diego Reynoso received a grant of 3,775 Common Shares on April 17, 2026 at a reported value of $6.47 per share. The shares were issued in lieu of cash for his service on the board of directors and are compensation, not an open-market purchase. Following this award, he directly holds 63,147 Common Shares.
Lemmon David J reported acquisition or exercise transactions in this Form 4 filing.
SunOpta Inc. director David J. Lemmon received a grant of 2,362 Common Shares on April 17, 2026 at a value of $6.47 per share. The shares were issued in lieu of cash for his service on the board of directors. Following this award, he directly holds 22,879 Common Shares.
Hollis Richard Dean reported acquisition or exercise transactions in this Form 4 filing.
SunOpta Inc. director Hollis Richard Dean received a grant of 3,197 Common Shares on April 17, 2026 at a value of $6.47 per share. The shares were issued in lieu of cash for service on the board of directors. Following this award, Dean directly holds 589,862 Common Shares.